Richard Chin, President and CEO at Kindred Biosciences, Inc. (KIN), sold 92,610 shares at $10.13 ($937K) on 2018-06-01, disclosed to the SEC on 2018-06-01.
Open-market sale of $936k KIN by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.00 | 12,610 | $126K | 13.5% |
| 2 | $10.13 | 40,000 | $405K | 43.3% |
| 3 | $10.13 | 40,000 | $405K | 43.3% |
| Total | $10.11 avg | 92,610 | $937K | 100% |
| Filing → |
| KIN | SELL | 2021-06-17 | $367K | — | Filing → |
| KIN | SELL | 2019-01-04 | $423K | — | Filing → |
| KIN | SELL | 2018-12-04 | $531K | — | Filing → |